OBJECTIVE: Following thoracic surgery, daily chest X-rays (CXRs) are performed to assess patient evolution and to make decisions regarding chest tube removal and patient discharge. Sonography after thoracic surgery (SATS) has the potential to be an effective, convenient, inexpensive and easy to learn tool in the post-operative management of thoracic surgery patients. We hypothesized that SATS could alleviate the need for repetitive CXRs, thus reducing the related risks, costs and inconvenience.
INTRODUCTION
Surgically induced pneumothorax and hydro-hemothorax are ubiquitously found in post-operative thoracic surgery patients. Tube thoracostomy is therefore needed to drain the air and effusion. Postoperative chest X-rays (CXRs) assessing the patient's chest, including the presence of a pneumothorax and hydrohemothorax, are performed either routinely or on demand depending on hospital or surgeon preference for decision making regarding chest tube removal and patient discharge [1, 2] . However, CXRs are costly, expose patients and healthcare workers to ionizing radiation, necessitate patient displacement with chest tubes and are time consuming.
Transthoracic ultrasonography has been proven adequate in identifying pneumothoraces, mainly in trauma populations [3] [4] [5] [6] . Pleural effusion identification and characterization with transthoracic ultrasonography have been thoroughly described [7] [8] [9] . This imaging modality is commonly used for this purpose in many settings. To our knowledge, the routine use of transthoracic ultrasonography in the post-operative thoracic surgery patient population has never been described. Performed at the patient's bedside, this method shows none of the disadvantages related to post-operative CXRs. In this prospective cohort trial, we hypothesized that sonography after thoracic surgery (SATS) performed by a surgical team member is an effective method for decision making, convenient, inexpensive and easy to learn. The objectives were to evaluate SATS's validity in identifying pneumothoraces and hydro-haemothoraces and to determine whether SATS could replace routine post-operative CXRs following thoracic surgery.
MATERIALS AND METHODS
From 21 June 2010 to 3 December 2010, all patients scheduled to undergo an elective open or thoracoscopic general thoracic surgery at the CHUM (Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada) were prospectively enrolled in the study. Patients <18 years old or unable to consent were excluded from the study. Written informed consent was obtained in the pre-operative clinic or during patient admission the day preceding their surgery. This study was approved by the institutional review board and the university hospital research centre.
Prior to opening the study and enrolling patients, the study investigators who would be performing the ultrasonographic examinations underwent a 2-week intensive learning phase. During this phase, they performed SATS on post-operative thoracic surgery patients and then compared their findings to the patient's same day CXR. When findings were inconsistent, the evaluators completed SATS a second time on the patient formerly examined to properly identify the findings that were misinterpreted the first time SATS was carried out. Patients participating in this learning phase were not included in the study.
Sample size estimates were based on the required precision of the psychometric properties, specifically sensitivity and specificity. In order to obtain 95% confidence intervals with a range of ±3, and 80% power calculations 120 patients were required to be enrolled in the assessment phase of the study.
Baseline patient characteristics (age, body mass index, comorbidities) were obtained from hospital records and patient interviews and recorded on standardized study report forms. Surgical procedure and operative details were obtained from patient hospital records.
Following surgery, one member of the research team approached patients and assessed if patients would be physically capable of undergoing SATS on that specific day. In some cases, patients refused chest ultrasound mainly because of postoperative pain. In case of patient refusal, patients were visited on the following day and again asked if they would accept to undergo SATS. This was repeated until their condition permitted SATS. In other cases, patients presenting altered consciousness were not assessed, but later could undergo SATS if this problem resolved.
SATS was performed by one of the three SATS evaluators and was performed in the same sequence as post-operative CXRs. All ultrasound examinations were completed at patient bedside using a GE LOGIQe portable ultrasound machine (GE Healthcare, Milwaukee, WI, USA) with cardiac GE 3S Convex (4 MHz) and vascular 12L-RS Linear (10 MHz) probes (GE Healthcare, Milwaukee, WI, USA). SATS was performed in a sitting position when possible. In patients unable to tolerate a sitting position, ultrasound examination was performed in a 45°supine position.
To assess the presence of pleural effusion, both probes (3S, 12L-RS) were used and the findings from each probe were recorded separately. The criteria used to identify pleural effusions ( Fig. 1) were anechoic or hypoechoic regions surrounded by anatomical boundaries (lung, diaphragm, chest wall). With each probe, the anterior, lateral and posterior costodiaphragmatic angles of each hemithorax were examined through the hepatic or splenic window. This was performed in all views between the anterior axillary line to the paravertebral line. If a pleural effusion was found, the upper and lower limits were identified and the size of the effusion measured (lung-diaphragm distance and maximum depth of the effusion). Other recorded characteristics included pleural effusion echogenecity and the presence of septa/loculations.
In order to detect pneumothoraces, solely the 10 MHz 12L-RS probe was used. The apices of the lungs were examined above and below the clavicle from the parasternal line to the anterior axillary line. The evaluator searched for the presence of lung sliding and comet-tail artefacts (Fig. 2 ). In the absence of those signs, a positive result for pneumothorax was recorded.
In certain cases, a complete SATS evaluation was not possible either because of limited patient mobility, which precluded a posterior evaluation, surgical dressing, or because of significant subcutaneous emphysema [9] .
None of the SATS evaluators had any prior training in chest ultrasound. The research team performing SATS was not part of the treating team. Patient care decision-making was solely based on CXRs and the results of the SATS examinations were not shared with the treating team in order to assure that all patients were treated based on the standard of care (CXR examination). SATS evaluators were blinded to the patients' CXRs.
The diagnostic gold standard was the CXR interpretations reported by dedicated chest radiologists at our institution. Study For statistical analysis, each hemithorax of each SATS examination was considered individually. Sensitivity, specificity, positive and negative predictive values (NPVs) were calculated based on all hemithoraces. Multivariable logistic regression analysis adjusting for age, sex, body mass index and open vs. thoracoscopic intervention was completed to find any association with true SATS findings (SPSS Inc., Chicago, Il, USA, version 19).
RESULTS
From 21 June 2010 to 3 December 2010, a total of 127 patients were enrolled in the study. Seven patients were not included in the analysis for the following reasons: surgery cancelled (n = 3), no comparative CXRs performed (n = 2) and patient withdrawal from the study after giving consent (n = 2). One hundred and twenty patients underwent SATS and remained for analysis. One hundred and twenty-one procedures were performed on the120 patients in the cohort; one patient having undergone two procedures.
The study group was 55% male (n = 66). The mean age was 60.2 years (standard deviation [SD] = 15.3 years, range, 18-83 years). Surgical interventions for the patient cohort are described in Table 1 .
Three hundred and fifty-two SATS examinations were performed. The mean number of examinations per patient was 3.0 (SD = 2.4, range 1-12). The average post-operative day on which SATS begun was 2.4 (SD = 1.9, range, 0-11). The mean length of stay was 10.8 days (SD = 11.0 days, range 2-78 days).
The time required to perform SATS was 11 ± 6 min per exam. The time interval between SATS and the comparative CXR acquisition was 166±149 min.
Pleural effusion
A total of 684 hemithoraces remained for analysis from the 352 SATS examinations after excluding the hemithoraces ipsilateral to pneumonectomies. SATS correctly identified 118 pleural effusions from the 148 pleural effusions reported by CXR. Within the 531 (77.6%) negative pleural effusions on CXR, SATS identified 305 of those as negative pleural effusions. Twenty-four findings were false negatives, 209 were false positives and 20 findings were non-conclusive with SATS. The latter include results from examinations on patients who presented limited mobility, important dressings or subcutaneous emphysema, thus making an adequate SATS evaluation unfeasible. To detect a pleural effusion with both probes (3S and 12L-RS), SATS yielded a sensitivity of 83.1%, a specificity of 59.3%, a positive predictive value (PPV) of 36.1% and a NPV of 92.7%. Considering the results obtained with the 3S probe alone, the sensitivity, specificity, PPV and NPV were 72.7, 70.0, 39.1 and 90.2%, respectively. The 12L-RS probe alone had a sensitivity, specificity, PPV and NPV of 76.3, 65.0, 37.3 and 90.9%, respectively. Detailed findings are presented in Table 2 . Multivariable logistic regression analysis revealed that a true positive or true negative SATS result was unrelated to age, sex, body mass index and open vs. thoracoscopic intervention.
Pneumothorax
Six hundred and eighty-four hemithoraces were kept for analysis for pneumothorax detection, excluding the hemithoraces ipsilateral to pneumonectomies. CXRs revealed 157 (23.0%) pneumothoraces and SATS identified 29 of these pneumothoraces. Within the 516 (75.4%) negative pneumothoraces on CXR, SATS concluded in the absence of a pneumothorax in 462 cases (Table 3) . In identifying pneumothoraces with the 12L-RS probe, the sensitivity, specificity, PPV and NPV are 21.2, 94.7, 52.7 and 81.1%, respectively. In CXR radiological reports, 64 of the 157 pneumothoraces (40.8%) were described as apical and 'very discrete', 'minimal', 'small' or pneumothoraces under 1 cm. Multivariable logistic regression analysis adjusted for age, sex, 
DISCUSSION
To our knowledge, there are no studies evaluating thoracic ultrasound in the post-operative setting following thoracic surgery. The presence of pleural effusion and of pneumothorax is investigated on a daily basis following the procedure, until patient discharge. This is most often done with daily CXRs, physical examination and chest tube assessment. In this trial, SATS failed to demonstrate that it could be used as an adequate investigation method in finding pneumothoraces in a post-operative setting. However, with the results obtained, SATS could be a feasible investigation modality in identification of pleural effusions in the post-operative thoracic surgery patient. Several publications have shown that thoracic ultrasonography is an accurate diagnostic method in detecting pneumothoraces in a trauma setting, following lung biopsies and in intensive care units [3] [4] [5] [6] [10] [11] [12] [13] . Studies have reported sensitivities ranging between 73 and 100% and specificities ranging between 68 and 100% [3, 6, 14, 15] . Compared with CXRs, thoracic ultrasound in an emergency department setting is more sensitive in finding pnemeumothoraces [16, 17] . In the current study, the sensitivity was only 21.2% and the specificity 94.7%. It is difficult to compare these results with the ones previously reported due to the difference in patient population and setting. In the current cohort, 41% of the pneumothoraces identified on CXR were of small size (3-10 mm), which are not comparable to the size of pneumothoraces observed in other settings, such as a trauma-induced pneumothorax. Furthermore, following thoracic surgery, the inflammation found within the pleural cavity could affect the interpretations of traditional ultrasonographic findings indicative of a pneumothorax. Indeed, pulmonary oedema can affect image resolution [9] . Accurate SATS findings for pneumothorax detection were positively associated with an open (thoractomy) surgical approach on multivariable analysis. For pulmonary interventions, this may be explained by larger air leaks associated with open lobectomy which are caused by open fissure dissection techniques in the thoracotomy approach compared with the anterior, fissure-less approach utilized during VATS lobectomy. Fissure-less dissection is associated with fewer and less severe air leaks in the post-operative period and hence one can expect larger pneumothoraces following pulmonary lobectomy carried out by thoracotomy.
The detection of pleural effusion in this study was associated with a sensitivity of 83.1% and a specificity of 59.3%. We believe that SATS could be an adequate method for post-operative pleural effusion follow-up and management. However, our results demonstrate that the best sensitivity is achieved only if a second probe is used to confirm the absence or presence of a pleural effusion in cases where the first probe fails to identify a pleural effusion. In general, the 3S probe identifies larger effusions and the 12L-RS probe smaller effusions.
Pleural effusion detection by thoracic ultrasound has been well studied. Ultrasound can detect a quantity of pleural fluid as minimal as 5 ml compared to CXR that requires a minimal fluid quantity of 150 ml on a postero-anterior CXR and of 50 ml on a lateral CXR [7, 8, 18] (Fig. 3) . Hence, we believe that because our diagnostic standard is less sensitive than SATS according to the literature, the specificity of SATS is in reality much greater than the one obtained.
A portable hand-held ultrasound machine like the one used for the study offers many advantages. SATS can be accomplished during morning rounds at the same time as physical examination, providing direct and dynamic information. Thus, decision regarding pleural effusion management would be taken at that same time, avoiding the time interval to obtain a CXR taken later during the day. Compared with CXR, SATS does not release ionizing radiation, reducing the exposure of frequently exposed patients to ionizing imaging modalities. Bedside ultrasound does not require patient displacement with chest tubes, reducing this inconvenience and potential injury risk during displacements. On a cost-effectiveness level, only the initial acquisition of the ultrasound machine represents an expense; afterwards, this examination does not require additional expense except for maintenance and repair. These advantages are interesting; however, SATS could not entirely replace CXR since it is not reliable in identifying pneumothoraces. These are important especially following chest tube removal. Selectively, SATS is beneficial for patients with a previously ruled out pneumothorax requiring only pleural effusion monitoring and evaluation. SATS provides high-quality images of effusions giving their precise site and boundaries. Because of this, it can also be used to assist interventions, such as thoracocenthesis and pigtail drainage. Thoracic ultrasound also has the advantage of differentiating transudates from exudates [19] . Post-operative CXR evaluation of the thoracic surgical patient is not only limited to the pleural space. Pulmonary parenchymal evaluation is often necessary to diagnose and follow pulmonary atelectasis and pneumonia. These were not evaluated in the current study with SATS, however have been looked at in nonthoracic surgical patients [20] [21] [22] [23] [24] and will be evaluated in future studies. Another consideration is the poor capacity or even inability of SATS to visualize the mediastinal pleura, the hilum and retrosternal space [9] . In fact, one patient had a persistant retrosternal hydropneumothorax that failed to be detected by SATS. Nonetheless, routine post-operative CXRs have been abandoned in some centres and have been replaced with an on-demand approach [1, 2] . Graham et al. and Mets et al. have reported that performing CXRs on an as-needed basis depending on patient clinical status does not significantly change outcomes compared to a routine CXR practice. This supports the use of SATS for selected patients in whom only pleural effusion assessment is indicated.
When chest tubes are in place, the output volume, effusion assessment as well as assessment of air leaks are important criteria to consider in decision making relating to timing of chest tube removal. Before chest tubes are removed, SATS is not only useful in identifying effusions, but also indicating effusion volume and loculations, which can also influence decision making. When a chest tube is blocked or separated from a loculated effusion, SATS can provide unique information on the residual effusion and can assist additional drainage procedures. Following chest tube removal, most patients are discharged; however, SATS is useful in monitoring residual pleural effusions in patients who remain admitted, who are readmitted for important pleural effusions or in the post-operative follow-up clinic.
One of the aims of this study was to determine whether SATS performed by someone with minimal training is feasible. With an intensive 2-week training period focused on basic chest ultrasound, we believe that, with the results obtained in pleural effusion detection with SATS, this is feasible. Therefore, SATS would be fast and easy to learn for surgeons and surgical residents. However, ultrasonography is known to be operator dependent. A major limitation to the current study is that interobserver agreement was not evaluated. This is due to the fact that it was not possible to have a second operator perform a second SATS examination for each ultrasound. Kataoka and Takada [25] studied interobserver agreement for pleural effusion detection in patients with decompensated congestive heart failure and obtained a 95% overall agreement and a kappa statistic of 0.70. We believe that a comparable interobserver agreement can be obtained in conditions similar to the ones in this study; however, this needs to be evaluated in future studies.
If SATS were to be completed during morning rounds, we believe that SATS would take less time to be completed than the average time needed in this study (11 min) since it would be integrated in the same visit. As evaluators gain experience, they become faster at performing SATS. Furthermore, since we are suggesting a potential role for selective use of SATS in patients only requiring pleural effusion evaluation, these patients are usually in late recovery period and more mobile, making the examinations faster and easier.
A relatively common limitation to SATS was subcutaneous emphysema. It was found on 110 hemithoraces. Usually unilateral and ipsilateral to the side of the surgery, it makes visualization by SATS nearly impossible locally. However, when it was limited to a region of the hemithorax, a partial evaluation was possible. Surgical closure sites and dressings also contributed to incomplete examinations. Limited patient mobility sometimes made posterior costodiaphragmatic angle difficult or impossible to visualize.
Strengths of the study include the heterogeneous group of patients having undergone the full gamut of general thoracic surgery procedures, the large sample size and the lack of prior knowledge of chest ultrasound in the SATS evaluators. Study limitations include the inability of some patients to undergo SATS early in the post-operative period due to pain and the reality of the gold standard test (CXR) not being sensitive enough to pick up small effusions and pneumothoraces.
In conclusion, post-operative ultrasound may alleviate the need to perform routine CXR in patients with a previously ruled out pneumothorax. SATS used selectively may be able to reduce 
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